Kirsty Mead brings over three decades of healthcare expertise to the Board of Neuroendocrine Cancer Australia, combining hands-on clinical experience with strategic leadership across the health sector. Beginning her career as a Registered Oncology Nurse, Kirsty has worked across Australia, New Zealand, Japan, and Vanuatu, gaining a deep understanding of consumer needs, public health, practitioner education, healthcare funding, and the complexities of integrating these elements.
Kirsty is deeply passionate about advancing health equity, particularly for under-recognised and underserved populations. She co-developed and led the national rollout of the Periods, Pain, and Endometriosis Program (PPEP Talk®) and its tailored versions for sports and First Nations communities. Her leadership roles with the Pelvic Pain Foundation of Australia and as a founding director of Australia’s Endometriosis Peak Body demonstrate her ability to translate clinical insights into impactful advocacy and strategic outcomes.
Guided by the belief that those with a voice must advocate for those without, she is committed to raising awareness, securing funding, and strengthening systemic support for neuroendocrine cancer patients and their families.
Kirsty is a mum of two young adults and two spoodles, a dedicated supporter of the theatre and a one-eyed Port Power Member.